Angiogenic and HIV-inhibitory functions of KSHV-encoded chemokines
- PMID: 9323208
- DOI: 10.1126/science.278.5336.290
Angiogenic and HIV-inhibitory functions of KSHV-encoded chemokines
Abstract
Unique among known human herpesviruses, Kaposi's sarcoma-associated herpesvirus (KSHV or HHV-8) encodes chemokine-like proteins (vMIP-I and vMIP-II). vMIP-II was shown to block infection of human immunodeficiency virus-type 1 (HIV-1) on a CD4-positive cell line expressing CCR3 and to a lesser extent on one expressing CCR5, whereas both vMIP-I and vMIP-II partially inhibited HIV infection of peripheral blood mononuclear cells. Like eotaxin, vMIP-II activated and chemoattracted human eosinophils by way of CCR3. vMIP-I and vMIP-II, but not cellular MIP-1alpha or RANTES, were highly angiogenic in the chorioallantoic assay, suggesting a possible pathogenic role in Kaposi's sarcoma.
Comment in
-
Kaposi's sarcoma and protection from HIV dementia.Science. 1998 Apr 17;280(5362):361-2. Science. 1998. PMID: 9575077 No abstract available.
Similar articles
-
Distinct chemotactic and angiogenic activities of peptides derived from Kaposi's sarcoma virus encoded chemokines.Int J Oncol. 2000 Jul;17(1):75-81. doi: 10.3892/ijo.17.1.75. Int J Oncol. 2000. PMID: 10853021
-
A broad-spectrum chemokine antagonist encoded by Kaposi's sarcoma-associated herpesvirus.Science. 1997 Sep 12;277(5332):1656-9. doi: 10.1126/science.277.5332.1656. Science. 1997. PMID: 9287217
-
Kaposi's sarcoma-associated herpesvirus (KSHV)-encoded vMIP-I and vMIP-II induce signal transduction and chemotaxis in monocytic cells.Arch Virol. 2003 May;148(5):871-90. doi: 10.1007/s00705-002-0971-7. Arch Virol. 2003. PMID: 12721796
-
Pathological Features of Kaposi's Sarcoma-Associated Herpesvirus Infection.Adv Exp Med Biol. 2018;1045:357-376. doi: 10.1007/978-981-10-7230-7_16. Adv Exp Med Biol. 2018. PMID: 29896675 Review.
-
Blocking HIV co-receptors by chemokines.Dev Biol Stand. 1999;97:105-9. Dev Biol Stand. 1999. PMID: 10463536 Review.
Cited by
-
Chemokines and viral diseases of the central nervous system.Adv Virus Res. 2001;56:127-73. doi: 10.1016/s0065-3527(01)56006-6. Adv Virus Res. 2001. PMID: 11450298 Free PMC article. Review.
-
Kaposi's sarcoma and its associated herpesvirus.Nat Rev Cancer. 2010 Oct;10(10):707-19. doi: 10.1038/nrc2888. Nat Rev Cancer. 2010. PMID: 20865011 Free PMC article. Review.
-
In vivo-restricted and reversible malignancy induced by human herpesvirus-8 KSHV: a cell and animal model of virally induced Kaposi's sarcoma.Cancer Cell. 2007 Mar;11(3):245-58. doi: 10.1016/j.ccr.2007.01.015. Cancer Cell. 2007. PMID: 17349582 Free PMC article.
-
Lytic replication-defective Kaposi's sarcoma-associated herpesvirus: potential role in infection and malignant transformation.J Virol. 2004 Oct;78(20):11108-20. doi: 10.1128/JVI.78.20.11108-11120.2004. J Virol. 2004. PMID: 15452231 Free PMC article.
-
The virus-encoded chemokine vMIP-II inhibits virus-induced Tc1-driven inflammation.J Virol. 2003 Jul;77(13):7393-400. doi: 10.1128/jvi.77.13.7393-7400.2003. J Virol. 2003. PMID: 12805438 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
Research Materials